Suchergebnisse - "Sarilumab"

PubPharm (319)

61

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

enthalten in: Joint bone spine | 2022

von Marotte, H. | Fakra, E. | Flipo, R. | +4

62

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

63

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis Research & Therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

64

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis Research & Therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

65

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

66

Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants

enthalten in: Biomedicines | 2022

von Lesmana, M. | Le, N. | Chiu, W. | +4

67

Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis

enthalten in: Expert opinion on drug discovery | 2022

von Maioli, G. | Caporali, R. | Favalli, E.

68

Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis : analysis of two Phase 3 randomised clinical trials

enthalten in: Modern rheumatology | 2022

von Tanaka, Y. | Takahashi, T. | Sumi, M. | +5

69

Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts

enthalten in: Pharmaceutics | 2022

von Klinder, A. | Waletzko-Hellwig, J. | Sellin, M. | +5

70

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Burmester, G. | Bykerk, V. | Buch, M. | +6